Ultralife Corporation (ULBI)
Official siteINDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ
Market Cap: $262.13M
Last updated: Nov 17, 2026 at 11:02 AM ET
Ultralife Corporation (ULBI) Financials: Revenue, Profit and Cash Flow
Ultralife reported revenue of $191.16M for the fiscal year ended Dec 31, 2025, up 16.2% from the year before. That year, net income was -$5.95M with a net margin of -3.1%, operating cash flow was $10.99M and free cash flow was $7.12M. The quarter ended Sep 30, 2026 had revenue of $48.27M and net income of $2.38M.
Revenue and Margins
The operating margin was -3.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $82.46M, a compound annual rate of 9.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $191.16M | +16.2% | 24.1% | -3.1% | -3.1% |
| Dec 2024 | $164.46M | +3.7% | 25.7% | 6.1% | 3.9% |
| Dec 2023 | $158.64M | +20.3% | 24.7% | 6.0% | 4.5% |
| Dec 2022 | $131.84M | +34.2% | 22.3% | 0.1% | -0.1% |
| Dec 2021 | $98.27M | -8.8% | 25.1% | 0.0% | -0.2% |
| Dec 2020 | $107.71M | +0.9% | 27.1% | 5.3% | 4.9% |
| Dec 2019 | $106.80M | +22.5% | 29.2% | 6.9% | 5.0% |
| Dec 2018 | $87.19M | +1.9% | 29.3% | 7.5% | 28.7% |
| Dec 2017 | $85.53M | +3.7% | 30.7% | 7.6% | 9.0% |
| Dec 2016 | $82.46M | N/A | 30.4% | 4.6% | 4.2% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $191.16M | $164.46M | $158.64M | $131.84M | $98.27M | $107.71M | $106.80M | $87.19M | $85.53M | $82.46M |
| Cost of revenue | $145.14M | $122.14M | $119.44M | $102.44M | $73.63M | $78.55M | $75.63M | $61.61M | $59.30M | $57.35M |
| Gross profit | $46.02M | $42.31M | $39.20M | $29.40M | $24.64M | $29.16M | $31.16M | $25.58M | $26.23M | $25.11M |
| Research and development | $10.40M | $8.27M | $7.53M | $7.08M | $6.83M | $5.95M | $6.80M | $4.51M | $4.74M | $5.95M |
| Operating income | -$5.90M | $9.96M | $9.47M | $129.00K | $35.00K | $5.70M | $7.37M | $6.55M | $6.48M | $3.76M |
| Net income | -$5.95M | $6.41M | $7.17M | -$120.00K | -$230.00K | $5.33M | $5.31M | $25.00M | $7.66M | $3.48M |
| EBITDA | $1.32M | $14.49M | $15.11M | $5.00M | $3.73M | $10.45M | $10.10M | $9.08M | $8.96M | $6.64M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48.27M | $47.94M | $47.45M | $48.48M | $43.37M | $48.56M | $50.75M | $43.85M | $35.69M | $42.98M | $41.93M | $44.55M |
| Gross profit | $13.29M | $13.87M | $10.11M | $12.06M | $9.62M | $11.60M | $12.74M | $10.60M | $8.68M | $11.56M | $11.47M | $11.40M |
| Operating income | $3.19M | $3.44M | -$215.00K | -$10.61M | -$951.00K | $2.26M | $3.40M | $1.47M | $511.00K | $3.92M | $4.06M | $3.65M |
| Net income | $2.38M | $2.52M | -$471.00K | -$7.45M | -$1.25M | $870.00K | $1.88M | $233.00K | $279.00K | $2.99M | $2.90M | $2.85M |
Balance Sheet
As of Dec 2025, total debt of $49.65M exceeded cash and equivalents by $40.31M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $216.91M | $220.45M | $178.28M | $168.43M | $159.54M | $137.70M | $144.56M | $120.85M | $97.19M | $84.74M |
| Current assets | $105.80M | $97.16M | $90.20M | $78.99M | $66.52M | $64.50M | $70.37M | $67.16M | $61.92M | $49.42M |
| Cash and equivalents | $9.35M | $6.85M | $10.28M | $5.71M | $8.41M | $10.65M | $7.41M | $25.93M | $18.24M | $10.63M |
| Total liabilities | $86.78M | $86.26M | $52.85M | $52.03M | $41.80M | $20.78M | $34.81M | $16.39M | $18.14M | $16.88M |
| Short-term debt | $4.13M | $2.75M | $2.00M | $2.00M | $2.00M | $1.36M | $1.37M | $0 | $0 | $0 |
| Long-term debt | $45.53M | $51.50M | $23.62M | $19.31M | $18.86M | $0 | $15.78M | $0 | $0 | $0 |
| Shareholder equity | $130.00M | $134.00M | $125.33M | $116.28M | $117.62M | $116.80M | $109.73M | $104.55M | $79.20M | $68.03M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $224.40M | $216.16M | $220.63M | $216.91M | $222.25M | $220.96M | $223.75M | $220.45M | $172.44M | $169.82M | $180.55M | $178.28M |
| Total liabilities | $89.77M | $83.56M | $90.89M | $86.78M | $84.81M | $82.32M | $87.15M | $86.26M | $37.81M | $36.47M | $51.61M | $52.85M |
| Cash and equivalents | $8.63M | $6.66M | $8.89M | $9.35M | $9.26M | $10.94M | $8.72M | $6.85M | $6.77M | $6.69M | $10.10M | $10.28M |
| Shareholder equity | $134.53M | $132.51M | $129.63M | $130.00M | $137.26M | $138.45M | $136.40M | $134.00M | $134.48M | $133.21M | $128.84M | $125.33M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 64.8% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.99M | $16.64M | $1.93M | -$1.26M | $4.33M | $21.72M | -$2.97M | $10.89M | $7.27M | $7.65M |
| Capital expenditures | $3.87M | $1.93M | $2.55M | $1.68M | $2.81M | $3.10M | $6.28M | $4.18M | $1.39M | $1.22M |
| Free cash flow | $7.12M | $14.70M | -$623.00K | -$2.94M | $1.51M | $18.62M | -$9.25M | $6.70M | $5.88M | $6.43M |
| Dividends paid | N/A | N/A | N/A | $15.00K | $250.00K | $148.00K | $930.00K | $0 | $0 | $0 |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | N/A | $1.96M | $742.00K | $0 | $607.00K |
| Investing cash flow | -$3.87M | -$49.95M | -$2.55M | -$1.68M | -$26.33M | -$2.98M | -$31.53M | -$4.18M | -$1.39M | -$11.08M |
| Financing cash flow | -$4.68M | $29.86M | $5.49M | $518.00K | $19.64M | -$15.69M | $16.12M | $1.17M | $1.40M | -$175.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.93M | $1.19M | $2.26M | $1.49M | $198.00K | $5.93M | $3.37M | $3.05M | $4.75M | $8.93M | -$81.00K | $2.43M |
| Capital expenditures | $591.00K | $453.00K | $770.00K | $882.00K | $995.00K | $1.10M | $895.00K | $606.00K | $594.00K | $360.00K | $372.00K | $1.00M |
| Free cash flow | -$3.52M | $735.00K | $1.49M | $607.00K | -$797.00K | $4.83M | $2.47M | $2.44M | $4.15M | $8.56M | -$453.00K | $1.43M |
Frequently Asked Questions About ULBI
What is Ultralife's annual revenue?
Ultralife reported revenue of $191.16M for the fiscal year ended Dec 31, 2025.
How fast is Ultralife's revenue growing?
Revenue was up 16.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 13.2%.
Is Ultralife profitable?
No. Ultralife reported net income of -$5.95M for the fiscal year ended Dec 31, 2025, with a net margin of -3.1%.
How much free cash flow does ULBI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $10.99M minus capital expenditures of $3.87M produced free cash flow of $7.12M.
How much debt does Ultralife have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $45.53M, short-term debt of $4.13M and cash and equivalents of $9.35M.
ULBI pages: Overview, Earnings, Financials, Valuation, Competitors, Government Contracts